O'NEILL GILMORE NEIL (CEO) sold 5.1% of their position (15.19K shares) of EDITAS MEDICINE, INC. on the open market
Open‑market sale worth $26.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/4/2025ACC: 0001650664-25-000089
DirectorOfficer· CEO
Since Jun 2022
-15.19K
Net shares
Net seller
$26.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
15.19K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−15.19K
Price / share
$1.72
Trade value
$26.20K
% of position
5.1%
6/3/2025
295.47K→280.28K
Total
Net shares
−15.19K
Net value
-$26.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/3/2025 | S · Sale | −15.19K | $1.72 | $26.20K | 5.1% | 295.47K | 280.28K |
| Total | −15.19K | -$26.20K | ||||||
Derivative Transactions0
No derivative transactions reported